ArticleBioinformatics (Oxford, England)2026
Detecting unannotated splicing events in short-read RNA-seq with SAMI, a UMI-aware Nextflow pipeline.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
summaryAlthough RNA-sequencing has replaced microarrays for gene expression profiling over the past 15 years, its full potential for splicing analysis in clinical settings remains underexploited. Most available tools are tailored for large cohorts or known isoforms, limiting their applicability in routine diagnostics where non-recurring events must be identified in low-dimension datasets. We present SAMI (Splicing Analysis with Molecular Indexes), a fully-integrated UMI-aware pipeline designed to detect splicing events diverging from transcript annotations. Building upon the well-proven STAR aligner, SAMI introduces original post-processing of gaps and potential intron retention to maximize accuracy, along with clear graphical representations and tunable filtering stringency. The ability of SAMI and concurrent software to detect intragenic splicing aberrations and gene fusions was assessed, both on real data from a commercial control sample and simulated data generated with ASimulatoR. AVAILABILITY AND IMPLEMENTATION: Nextflow pipeline and Singularity container recipe freely available under GPL 3 license at https://github.com/HCL-HUBL/SAMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.